Literature DB >> 4571048

Immune response of patients with rheumatoid arthritis during cyclophosphamide treatment.

J E Curtis, J T Sharp, M D Lidsky, E M Hersh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4571048     DOI: 10.1002/art.1780160106

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  7 in total

1.  Treatment of rheumatoid arthritis with levamisole: long-term results and immune changes.

Authors:  L A Runge; R S Pinals; R H Tomar
Journal:  Ann Rheum Dis       Date:  1979-04       Impact factor: 19.103

2.  Cyclophosphamide suppression of established cell-mediated immunity. Quantitative vs. qualitative changes in lymphocyte populations.

Authors:  J E Balow; D L Hurley; A S Fauci
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

Review 3.  Clinical use of immunosuppressive drugs: part I.

Authors:  N L Gerber; A D Steinberg
Journal:  Drugs       Date:  1976       Impact factor: 9.546

4.  Delayed cutaneous hypersensitivity in rheumatoid arthritis: the influence of nutrition and drug therapy.

Authors:  M G Helliwell; G S Panayi; A Unger
Journal:  Clin Rheumatol       Date:  1984-03       Impact factor: 2.980

5.  Evaluation of the immunosuppressive effects of cyclophosphamide in patients with multiple sclerosis.

Authors:  R J ten Berge; H K van Walbeek; P T Schellekens
Journal:  Clin Exp Immunol       Date:  1982-12       Impact factor: 4.330

6.  Activation of human B lymphocytes. XII. Differential effects of in vitro cyclophosphamide on human lymphocyte subpopulations involved in B-cell activation.

Authors:  H C Stevenson; A S Fauci
Journal:  Immunology       Date:  1980-03       Impact factor: 7.397

7.  Cell-mediated immunity in rheumatoid arthritis.

Authors:  A A Andrianakos; J T Sharp; D A Person; M D Lidsky; J Duffy
Journal:  Ann Rheum Dis       Date:  1977-02       Impact factor: 19.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.